1. Home
  2. RYZ vs NBTX Comparison

RYZ vs NBTX Comparison

Compare RYZ & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$28.29

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYZ
NBTX
Founded
1842
2003
Country
United States
France
Employees
4300
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
RYZ
NBTX
Price
$28.29
$39.72
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
349.5K
75.3K
Earning Date
05-06-2026
03-31-2026
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$75.79
$58.17
Revenue Next Year
$2.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.34
$4.10
52 Week High
$29.03
$57.14

Technical Indicators

Market Signals
Indicator
RYZ
NBTX
Relative Strength Index (RSI) 60.96 48.15
Support Level $23.47 $38.89
Resistance Level $29.03 $41.89
Average True Range (ATR) 1.15 3.32
MACD 0.23 -1.31
Stochastic Oscillator 88.90 6.08

Price Performance

Historical Comparison
RYZ
NBTX

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: